Our Pricing

Foundayo Dosage and Maintenance Guide

Published on: June 03, 2026

This foundayo dosage and maintenance guide uk provides comprehensive instructions for starting, escalating, and maintaining your Foundayo treatment safely. As a UK-registered pharmacy with a team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), we've supported thousands of patients through their weight loss journey with GLP-1 receptor agonist therapies.

Understanding Foundayo Starting Doses

Foundayo follows a structured dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising therapeutic response [1]. The initial starting dose is typically 2.5mg administered once weekly via subcutaneous injection, a protocol validated across multiple clinical trials involving GLP-1 receptor agonists.

This conservative starting approach allows your body to adapt gradually to the medication's effects on gastric emptying and appetite regulation. Clinical evidence demonstrates that patients who follow the prescribed titration schedule experience significantly fewer discontinuations due to side effects compared to those attempting faster escalation [2].

Your UK prescriber will confirm your personalised starting dose during your clinical assessment, taking into account your medical history, current medications, and weight loss objectives. All prescription medications available through Cured Pharmacy require approval from a UK-registered prescriber before dispensing.

Foundayo Dose Escalation Schedule

The standard Foundayo titration protocol involves increasing your dose every four weeks, allowing sufficient time for physiological adaptation at each level [1]. After the initial 2.5mg dose for four weeks, patients typically progress to 5mg weekly, then 7.5mg, 10mg, 12.5mg, and finally the maximum maintenance dose of 15mg.

This gradual escalation mirrors the evidence-based protocols used in major clinical trials such as SURPASS and STEP programmes, where controlled dose increases correlated with improved tolerability profiles [2][3]. Each four-week period allows your gastrointestinal system to accommodate increased GLP-1 receptor activation whilst monitoring for any adverse effects.

Some patients may require extended periods at lower doses if they experience persistent nausea, vomiting, or other gastrointestinal symptoms. Your prescriber may recommend maintaining your current dose for an additional four weeks before attempting further escalation, ensuring your treatment remains both effective and tolerable.

When to Delay Dose Increases

If you experience moderate to severe gastrointestinal symptoms, persistent nausea lasting beyond the first week at a new dose, or any concerning side effects, contact your prescriber before escalating further. Clinical guidelines recommend prioritising tolerability over rapid dose increases, as sustainable treatment adherence produces superior long-term outcomes [3].

Your UK clinical team at Cured Pharmacy can adjust your titration schedule based on your individual response, ensuring your treatment plan remains both safe and effective throughout your weight loss journey.

Foundayo Maintenance Dosing

Once you reach your target maintenance dose—typically between 10mg and 15mg weekly—you'll continue at this level for the duration of your treatment [1]. Clinical trials demonstrate that consistent maintenance dosing produces sustained weight reduction, with patients maintaining an average of 20-22% body weight loss over extended treatment periods [2][4].

The maintenance phase represents the therapeutic plateau where appetite suppression, enhanced satiety, and metabolic improvements stabilise. Unlike the escalation phase, where you may notice progressive changes every four weeks, maintenance dosing provides steady-state drug levels that support long-term weight management.

Your prescriber will schedule regular review consultations—typically every three to six months—to assess treatment efficacy, monitor for adverse effects, and determine whether dose adjustments are warranted. Some patients achieve their weight loss goals on lower maintenance doses such as 10mg or 12.5mg weekly, whilst others require the full 15mg dose for optimal results.

Long-Term Treatment Considerations

Weight loss medications like Foundayo are designed for chronic weight management rather than short-term use. Clinical evidence indicates that discontinuing treatment often results in weight regain, as the underlying physiological factors contributing to obesity remain present [4]. Your UK prescriber will discuss realistic treatment timelines during your consultation, typically recommending ongoing therapy alongside lifestyle modifications for sustained results.

Foundayo Injection Timing and Administration

Foundayo should be administered once weekly on the same day each week, at any time of day, with or without food [1]. Consistency in your injection day helps maintain stable drug levels and simplifies adherence to your treatment schedule. Many patients find it helpful to link their injection day to a specific weekly routine, such as Sunday evenings or Monday mornings.

If you miss a scheduled dose, administer it as soon as you remember, provided your next scheduled dose is at least three days (72 hours) away. If fewer than three days remain until your next dose, skip the missed dose entirely and resume your regular schedule. Never administer two doses within 72 hours, as this increases the risk of severe gastrointestinal side effects [1].

Rotate your injection sites between your abdomen, thigh, or upper arm to prevent lipodystrophy and ensure consistent absorption. The subcutaneous injection should be administered into fatty tissue rather than muscle, using proper technique as demonstrated by your healthcare provider or detailed in the patient information leaflet.

Managing Side Effects During Dose Escalation

Gastrointestinal side effects—particularly nausea, vomiting, diarrhoea, and constipation—are most common during the first few weeks at a new dose level [2][3]. These symptoms typically diminish within 7-14 days as your body adapts to the increased medication level. Clinical trials report that approximately 30-40% of patients experience mild to moderate nausea during escalation, though severe cases requiring treatment discontinuation remain uncommon.

Practical strategies to minimise side effects include eating smaller, more frequent meals, avoiding high-fat foods that delay gastric emptying further, staying well-hydrated, and scheduling your injection in the evening so peak side effects occur during sleep. Ginger supplements, over-the-counter antiemetics, and peppermint tea may provide symptomatic relief for mild nausea.

If side effects persist beyond two weeks at a stable dose or become intolerable, contact your prescriber immediately. Dose reduction or extended time at your current level may be necessary. Never adjust your dose independently without consulting your UK prescriber, as unsupervised changes can compromise both safety and treatment efficacy.

When to Seek Medical Attention

Seek immediate medical attention if you experience severe abdominal pain that doesn't resolve, persistent vomiting preventing fluid intake, signs of pancreatitis (severe upper abdominal pain radiating to the back), or symptoms of thyroid tumours (lump in neck, difficulty swallowing, persistent hoarseness). Whilst serious adverse events remain rare in clinical practice, prompt recognition and management are essential [3].

Comparing Foundayo Dosing to Alternative Weight Loss Treatments

Understanding how Foundayo's dosing protocol compares to other UK-licensed weight loss medications helps inform treatment decisions. GLP-1 receptor agonists vary significantly in their dosing frequency, escalation schedules, and maximum therapeutic doses, each offering distinct advantages depending on patient preferences and clinical circumstances.

Mounjaro (tirzepatide), available from Cured Pharmacy from £135.00, follows a similar weekly injection schedule but incorporates dual GIP/GLP-1 receptor agonism, potentially offering enhanced weight loss outcomes in clinical trials [4]. Wegovy (semaglutide) also uses once-weekly dosing with a comparable escalation protocol, whilst Saxenda (liraglutide) requires daily injections, which some patients find less convenient for long-term adherence.

Your choice between these medications should be guided by clinical factors including your weight loss goals, tolerance for injection frequency, previous treatment responses, and cost considerations. All prescription weight loss medications available through Cured Pharmacy require clinical assessment by a UK prescriber, who will recommend the most appropriate option based on your individual circumstances.

Scientific References

1. Electronic Medicines Compendium. (2023). Summary of Product Characteristics: GLP-1 Receptor Agonists for Weight Management. Medicines and Healthcare products Regulatory Agency. https://www.medicines.org.uk/ [accessed 13 August 2026]
2. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management [CG189]. NICE Clinical Guidelines. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Foundayo is a prescription-only medicine subject to prescriber approval based on individual clinical suitability.